Liver Cancer Treatment — Extreme Drug Resistance
Learn More About EDR for Liver Cancer: Chat with Us | Email Us
Extreme Drug Resistance for Liver Cancer
The Extreme Drug Resistance (EDR) Assay (also known as chemoresistance, or chemotherapy drug resistance test) is one innovative way that Cancer Treatment Centers of America (CTCA) can create a customized liver cancer treatment plan for you. Designed for solid tumors, the EDR is a highly accurate laboratory test that determines how resistant your liver cancer tumor may be to different chemotherapeutic drugs.
If the liver cancer cells grow in the presence of extreme exposure to a chemotherapy drug, this indicates the presence of significant drug resistance. Therefore, if the tumor is resistant to a drug in this assay, then the tumor growing in a liver cancer patient’s body will almost certainly be resistant to that drug. With this information, physicians at CTCA can avoid unnecessary toxicity and side effects, consider other treatment protocols, and minimize costs during your liver cancer treatment.